- Home
- CIVI vs APLS Comparison
CIVI vs APLS Comparison
Compare CIVI & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIVI
- APLS
- Stock Information
- Founded
- CIVI 1999
- APLS 2009
- Country
- CIVI United States
- APLS United States
- Employees
- CIVI N/A
- APLS N/A
- Industry
- CIVI Oil & Gas Production
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- CIVI Energy
- APLS Health Care
- Exchange
- CIVI Nasdaq
- APLS Nasdaq
- Market Cap
- CIVI 2.5B
- APLS 2.2B
- IPO Year
- CIVI 2011
- APLS 2017
- Fundamental
- Price
- CIVI $30.37
- APLS $22.34
- Analyst Decision
- CIVI Buy
- APLS Buy
- Analyst Count
- CIVI 11
- APLS 18
- Target Price
- CIVI $46.50
- APLS $35.41
- AVG Volume (30 Days)
- CIVI 1.6M
- APLS 2.5M
- Earning Date
- CIVI 08-06-2025
- APLS 07-31-2025
- Dividend Yield
- CIVI 9.95%
- APLS N/A
- EPS Growth
- CIVI 5.61
- APLS N/A
- EPS
- CIVI 8.73
- APLS N/A
- Revenue
- CIVI $5,071,808,000.00
- APLS $754,649,000.00
- Revenue This Year
- CIVI N/A
- APLS $10.84
- Revenue Next Year
- CIVI N/A
- APLS $10.51
- P/E Ratio
- CIVI $3.48
- APLS N/A
- Revenue Growth
- CIVI 22.15
- APLS 20.02
- 52 Week Low
- CIVI $22.79
- APLS $16.10
- 52 Week High
- CIVI $71.06
- APLS $41.94
- Technical
- Relative Strength Index (RSI)
- CIVI 49.58
- APLS 69.42
- Support Level
- CIVI $28.82
- APLS $18.48
- Resistance Level
- CIVI $33.12
- APLS $20.40
- Average True Range (ATR)
- CIVI 1.41
- APLS 1.17
- MACD
- CIVI 0.13
- APLS 0.11
- Stochastic Oscillator
- CIVI 51.75
- APLS 75.98
About CIVI Civitas Resources Inc.
Civitas Resources Inc is an independent exploration and production company engaged in the acquisition, development, and production of oil and associated liquids-rich natural gas in the Rocky Mountain region, in the Denver-Julesburg Basin of Colorado - DJ Basin. The company's operations are focused on developing the horizontal Niobrara and Codell formations that have a low-cost structure, mature infrastructure, production efficiencies, multiple producing horizons, multiple service providers, established reserves, and prospective drilling opportunities.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.